Jackson Square Partners’s Core Laboratories CLB Stock Holding History
Bought
Maintained
Sold
Other funds holding CLB
EIP
Jackson Square Partners's CLB Position: Q4 2018 in Review
Jackson Square Partners sold out of Core Laboratories (CLB) in Q4 2018, closing a stake of 415,083 shares — an estimated $48.1M sold.
Jackson Square Partners first reported a position in CLB in Q2 2014 and held it in 18 quarters. The position peaked at $234M in Q2 2016. 320 funds tracked by Wall St. Rank hold CLB as of Q4 2018.
- Jackson Square Partners reported no remaining Core Laboratories position as of Q4 2018 after selling out during the quarter.
- Jackson Square Partners sold 415,083 Core Laboratories shares in Q4 2018, an estimated $48.1M.
- Jackson Square Partners first reported a position in Core Laboratories in Q2 2014 and held it in 18 quarters.
- Jackson Square Partners's Core Laboratories position peaked at $234M in Q2 2016.
- 320 funds tracked by Wall St. Rank held Core Laboratories as of Q4 2018.
Based on Jackson Square Partners's 13F filing for Q4 2018, filed 13 Feb 2019.